Development services for minimally invasive glaucoma surgery (MIGS) device

urn:tendersight:notices:types:no-doffin:announcement-of-conclusion-of-contracturn:tendersight:notices:types:no-doffin:announcement-of-conclusion-of-contract2026-114934IAInven2 AS
Estimated valueNOK 3,000,000
Deadline—
Competition00 participants
Lots11 lot

Keep momentum on this opportunity

Save it on this device now. Create an account when you are ready to track deadlines, notes, and teamwork.

  • Save and reuse search filters
  • Track opportunities as pursuits
  • Get notified when new notices match
Quick actions

Keep this notice in a shortlist so you can return to it without starting a bid.

Keep notes, monitor deadlines and collaborate with your team. This does not submit a bid or contact the buyer.

Receive alerts

Key information

Identifier
Contract type
—
Deadline
—
CPV codes
73000000 - Research and development services and related consultancy services33000000 - Medical equipments, pharmaceuticals and personal care products33122000 - Ophthalmology equipment
Status
urn:tendersight:notices:procedure-statuses:no-doffin:awarded
Notice type
urn:tendersight:notices:types:no-doffin:announcement-of-conclusion-of-contracturn:tendersight:notices:types:no-doffin:announcement-of-conclusion-of-contract
Estimated value
NOK 3,000,000
Publication date
23 Sept 2026, 22:00

Overview

We are seeking quotes for the development and manufacturing of a multi-lumen stent intended for minimally invasive glaucoma surgery (MIGS). The device is designed to lower intraocular pressure (IOP), a key factor in the progression of glaucoma, with the ability to regulate pressure post insertion. The development scope, estimated to about 2 years of development, includes optimizing the stent design using in silico modeling, prototyping, and in vitro testing with ocular models and extracted pig eyes. Manufacturing will involve precision techniques such as microscale injection molding and extrusion, ensuring the production of a batch that meets the standards for preclinical testing. Approximately 100 units are planned for manufacturing to support the initial in vitro testing and a preclinical efficacy study in pigs.

Konkurranse med fohandling uten forutgående kunngjøring

Oslo (NO081), Norge

Prosedyreidentifikator: e42c1ba2-bf6c-4de9-b1f9-6aed5fa1a69b Intern identifikator: 5682 Varselidentifikator (eForms): 74735805-a160-4bee-8396-70ffcde159c2 TED: 657135-2026

Mottatte tilbud: 0 Tilbud levert elektronisk: 1

Kunngjøring om kontrakt eller konsesjonstildeling – standardregime

Contracting authorities1

IA

ORGNR 995495899

noOslo, Norway
[email protected]

Lots1

Documentation0

The source system does not support document syncing.

Award criteria0

No procedure-level award criteria recorded.

Participants1